布地奈德泡沫剂用于溃疡性直肠炎和直肠乙状结肠炎 - Suppr

[Budesonide foam for ulcerative proctitis and proctosigmoiditis].

作者信息

Bachmann O, Nitschmann S

机构信息

Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland,

出版信息

Internist (Berl). 2015 Jun;56(6):713-5. doi: 10.1007/s00108-015-3721-0.

DOI:10.1007/s00108-015-3721-0

PMID:25991492

Abstract

摘要

相似文献

[Budesonide foam for ulcerative proctitis and proctosigmoiditis].

Internist (Berl). 2015 Jun;56(6):713-5. doi: 10.1007/s00108-015-3721-0.

Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis.

Gastroenterology. 2015 Apr;148(4):740-750.e2. doi: 10.1053/j.gastro.2015.01.037. Epub 2015 Jan 30.

Topical therapy in ulcerative colitis: always a bridesmaid but never a bride?

Gastroenterology. 2015 Apr;148(4):701-4. doi: 10.1053/j.gastro.2015.02.038. Epub 2015 Feb 24.

Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies.

Inflamm Bowel Dis. 2016 Aug;22(8):1881-6. doi: 10.1097/MIB.0000000000000860.

Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis.

Dig Dis Sci. 2015 Nov;60(11):3408-17. doi: 10.1007/s10620-015-3868-5. Epub 2015 Sep 19.

Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis.

Aliment Pharmacol Ther. 2006 Jan 15;23(2):303-12. doi: 10.1111/j.1365-2036.2006.02743.x.

Colonic spread and serum pharmacokinetics of budesonide foam in patients with mildly to moderately active ulcerative colitis.

Aliment Pharmacol Ther. 2005 Sep 1;22(5):463-70. doi: 10.1111/j.1365-2036.2005.02571.x.

Budesonide foam vs. hydrocortisone acetate foam in the treatment of active ulcerative proctosigmoiditis.

Dis Colon Rectum. 2003 Jul;46(7):929-36. doi: 10.1007/s10350-004-6687-x.

[Treating distal ulcerative colitis intrarectally. Foam instead of enema, low volume rather than high volume].

MMW Fortschr Med. 2008 Apr 10;150(15):44.

On the efficacy of ready-made-up commercially available salicylazosulphapyridine enemas in the treatment of proctitis, proctosigmoiditis and ulcerative colitis involving rectum, sigmoid and descending colon.

Hepatogastroenterology. 1980 Dec;27(6):473-6.

本文引用的文献

Topical therapy is underused in patients with ulcerative colitis.

J Crohns Colitis. 2014 Jan;8(1):56-63. doi: 10.1016/j.crohns.2013.03.005. Epub 2013 Apr 6.

Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis.

Aliment Pharmacol Ther. 2006 Jan 15;23(2):303-12. doi: 10.1111/j.1365-2036.2006.02743.x.

Controlled, open, randomized multicenter trial comparing the effects of treatment on quality of life, safety and efficacy of budesonide foam and betamethasone enemas in patients with active distal ulcerative colitis.

Hepatogastroenterology. 2004 Sep-Oct;51(59):1345-9.

Budesonide foam vs. hydrocortisone acetate foam in the treatment of active ulcerative proctosigmoiditis.

Dis Colon Rectum. 2003 Jul;46(7):929-36. doi: 10.1007/s10350-004-6687-x.

[Budesonide foam as a new therapeutic principle in distal ulcerative colitis in comparison with mesalazine enema. An open, controlled, randomized and prospective multicenter pilot study].

Z Gastroenterol. 2000 Apr;38(4):287-93. doi: 10.1055/s-2000-14869.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Budesonide foam for ulcerative proctitis and proctosigmoiditis].

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献